Sundyota Numandis Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2003.
2003 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Sundyota Numandis Pharmaceuticals Private Limited

Sundyota Numandis Pharmaceuticals Private Limited, a active private limited company, was established on 29 May 2003 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239GJ2003PTC042438. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.30 Cr and a paid-up capital of ₹3.30 Cr.

Formerly known as Dyota Numandis Pharmaceuticals Private Limited. It upholds a compliant status. Employing 310 professional, Its leadership includes Poonam Arora (Director), Dinesh Kumar Arora (Managing Director). Past directors included Poonam Arora, Urmilaben Ravindra Bhatt, Smita Ravindra Bhatt. It holds ₹65.43 Cr open charges and ₹5.39 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Dyotanumandishouse,7Thfloor,Tower-'A',Safalpegasus,100Ft.Road,Prahladnagar, Ahmedabad, Gujarat, 380015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239GJ2003PTC042438

  • Registration Number

    042438

  • Incorporation Date

    29 May 2003

  • Authorized Capital

    ₹3.30 Cr

  • Paid-Up Capital

    ₹3.30 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.30 Cr
  • Paid Up Capital ₹ 3.30 Cr
  • Company Age 22 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 65.43 Cr
  • Satisfied Charges ₹ 5.39 Cr
  • Revenue Growth **** 0.81%
  • Profit Growth **** -24.21%
  • Ebitda **** -18.25%
  • Net Worth 12.71%
  • Total Assets -2.05%
Company report

Sundyota Numandis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sundyota Numandis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sundyota Numandis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Poonam Arora Director 24 Jul 2012 Current
Dinesh Kumar Arora Managing Director 29 May 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2012 Past
Pramod Abcsdd Director 20 Nov 2009 Past
Pramod Abcsdd Director 23 Feb 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sundyota Numandis Pharmaceuticals.

Sundyota Numandis Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.81% increase. The company also saw a substantial fall in profitability, with a 24.21% decrease in profit. The company's net worth Soared by an impressive increase of 12.71%.

Sundyota Numandis Pharmaceuticals revenue growth over time
Sundyota Numandis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.81%
*******
*******
*******
*******
Revenue from Operations
*******
 2.16%
*******
*******
*******
*******
Total Assets
*******
 -2.05%
*******
*******
*******
*******
Profit or Loss
*******
 -24.21%
*******
*******
*******
*******
Net Worth
*******
 12.71%
*******
*******
*******
*******
EBITDA
*******
 -18.25%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sundyota Numandis Pharmaceuticals?

In 2024, Sundyota Numandis Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹654,250,000.00

Satisfied Charges

₹53,900,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 58.78 Cr
  • Others : 6.65 Cr
Latest Charge Details
Date Lender Amount Status
25 Jan 2019 State Bank Of India ₹17.28 Cr Open
25 Jan 2019 State Bank Of India ₹41.50 Cr Open
22 Sep 2009 Others ₹6.65 Cr Open
07 Apr 2008 3I Infotech Trusteeship Services Limited ₹2.57 Cr Satisfied
03 May 2007 Icici Bank Limited ₹2.07 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sundyota Numandis Pharmaceuticals?

Sundyota Numandis Pharmaceuticals has a workforce of 310 employees as of Mar 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sundyota Numandis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundyota Numandis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sundyota Numandis Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sundyota Numandis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Sundyota Numandis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 6.65 Cr registered on 22 Sep 2009 with Charge ID 10178662 was modified on 31 May 2024. was documented.

  • Charges

    A charge with State Bank Of India of Rs. 17.28 Cr registered on 25 Jan 2019 with Charge ID 100246560 was modified on 06 Oct 2020. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 41.50 Cr with Charge ID 100246563 was registered on 25 Jan 2019. was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 17.28 Cr with Charge ID 100246560 was registered on 25 Jan 2019. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sundyota Numandis Pharmaceuticals Private Limited?

The CIN of Sundyota Numandis Pharmaceuticals Private Limited is U24239GJ2003PTC042438.

Where is Sundyota Numandis Pharmaceuticals Private Limited headquartered?

Sundyota Numandis Pharmaceuticals Private Limited is headquartered at Dyotanumandishouse,7Thfloor,Tower-'A',Safalpegasus,100Ft.Road,Prahladnagar, Ahmedabad, Gujarat, 380015.

When was Sundyota Numandis Pharmaceuticals Private Limited incorporated?

Sundyota Numandis Pharmaceuticals Private Limited was incorporated on 29 May 2003.

Who are the current directors of Sundyota Numandis Pharmaceuticals Private Limited?

The current directors of Sundyota Numandis Pharmaceuticals Private Limited are

What is the primary industry of Sundyota Numandis Pharmaceuticals Private Limited?

The primary industry of Sundyota Numandis Pharmaceuticals Private Limited is Trade.

Is Sundyota Numandis Pharmaceuticals Private Limited a listed company?

Sundyota Numandis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sundyota Numandis Pharmaceuticals Private Limited?

The authorized capital of Sundyota Numandis Pharmaceuticals Private Limited is ₹3.30 Cr, and the paid-up capital is ₹3.30 Cr.

What is the compliance status of Sundyota Numandis Pharmaceuticals Private Limited?

The compliance status of Sundyota Numandis Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available